22 percent of those over 50 hospitalized with RSV had acute cardiac events: study
By
Kristen Fischer
Apr 16, 2024
About a quarter of people over the age of 50 with respiratory syncytial virus (RSV) experienced acute cardiac events, according to a new study. Furthermore, the risk for severe outcomes in those who had...
Clinical briefs for Tuesday, April 9
By
Kristen Fischer
Apr 09, 2024
Hospitalizations didn’t go down after use of algorithm to identify diabetes, hypertension, kidney disease … Oral vaccine worked well to stop urinary tract infections … App program could lower urinary...
Clinical briefs for Friday, April 5
By
Kristen Fischer
Apr 05, 2024
Popular diabetes drugs could help with Parkinson’s disease … RSV was as severe as COVID-19, flu in unvaccinated before vaccine rollout … Why older adults don’t respond to vaccines as strongly...
Clinical briefs for Friday, March 8
By
Kristen Fischer
Mar 08, 2024
People with essential tremor more likely to get dementia … Test better targets pneumonia treatments … Type 2 diabetes education lacks in patients with disease … Shortages of tetanus-diphtheria shot...
Older adults, immunocompromised net biggest benefits from COVID-19 boosters, model shows
By
Kristen Fischer
Mar 07, 2024
A new model estimates that people over 65 or those who are immunocompromised benefit the most from COVID-19 booster shots.
Ask the care expert … about billing for RSV vaccines
By
Sherrie Dornberger
Mar 05, 2024
Q: I am the infection preventionist at my skilled care facility. How can I advise my office to order and bill for RSV vaccines? A: Many specialists and facilities are having difficulty implementing the...
CDC urges older Americans to get COVID-19 booster this spring
By
Kristen Fischer
Mar 01, 2024
The Centers for Disease Control and Prevention encourages older adults to get COVID-19 booster shots this spring, even if they received the vaccine in the fall.
Clinical briefs for Wednesday, Feb. 21
By
Kristen Fischer
Feb 21, 2024
COVID-19 vaccines, treatments still lack for older adults, analysis finds … Respiratory virus season may be over, CDC says … Phase 2 trial of CNM-Au8 for Parkinson’s promising … Depression risk...
Clinical briefs for Friday, Feb. 9
By
Kristen Fischer
Feb 09, 2024
Music is a mental, physical health booster … 1 in 5 Indian adults have mild neurocognitive disorder, data shows … Vaccine-makers eye antibiotic resistance as new goal … Report: FDA has weak oversight...
Report: More research needed to understand RSV prevalence, vaccine efficacy
By
Kristen Fischer
Feb 07, 2024
Researchers need to study respiratory syncytial virus (RSV) more in the older adult population because the prevalence of the virus isn’t clear, which could affect treatment, according to a new report.